Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
ID SYSTEMS INC (IDSY)
|
Add to portfolio |
|
|
|
| Price: |
$4.92
| | Metrics |
| OS: |
18.4
|
M
| |
-30
|
% ROE
|
| Market cap: |
$90.8
|
M
| |
-52
|
% ROIC
|
|
Net cash:
|
$8.1
|
M
| |
$0.44
|
per share
|
|
EV:
|
$82.7
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
($6.8)
|
M
| |
|
|
|
EBIT
|
($8.4)
|
M
| |
|
|
| EPS |
($0.49)
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 | Dec-31-13 | Dec-31-12 | Dec-31-11 |
| Revenues | 53.1 | 41.0 | 36.8 | 41.8 | 45.6 | 39.9 | 44.6 | 39.3 |
| Revenue growth | 29.6% | 11.2% | -11.9% | -8.4% | 14.2% | -10.5% | 13.6% | 51.9% |
| Cost of goods sold | 27.3 | 20.0 | 18.5 | 24.8 | 25.6 | 22.0 | 21.7 | 18.7 |
| Gross profit | 25.8 | 20.9 | 18.3 | 17.0 | 20.0 | 17.9 | 22.9 | 20.6 |
| Gross margin | 48.6% | 51.1% | 49.7% | 40.7% | 43.8% | 44.8% | 51.4% | 52.3% |
| Selling, general and administrative | 24.7 | 20.5 | 19.4 | 22.8 | 25.1 | 21.8 | 22.4 | 22.0 |
| Research and development | 6.9 | 4.6 | 5.2 | 4.6 | 6.6 | 4.4 | 4.3 | 3.5 |
| EBIT | -5.7 | -4.1 | -6.4 | -10.3 | -12.2 | -8.2 | -3.8 | -5.0 |
| EBIT margin | -10.8% | -10.0% | -17.3% | -24.6% | -26.7% | -20.6% | -8.6% | -12.6% |
| Pre-tax income | -5.8 | -4.2 | -6.4 | -10.0 | -11.6 | -7.6 | -3.3 | -4.4 |
| Income taxes | 0.0 | -0.3 | 0.0 | 0.0 | 0.0 | -0.1 | -0.7 | -0.4 |
| Tax rate | 0.0% | 7.4% | 0.0% | 0.0% | 0.0% | 0.8% | 20.3% | 8.8% |
| Net income | -5.8 | -3.9 | -6.4 | -10.0 | -11.6 | -7.5 | -2.6 | -4.0 |
| Net margin | -11.0% | -9.4% | -17.3% | -23.8% | -25.4% | -18.8% | -5.8% | -10.3% |
| |
| Diluted EPS | ($0.34) | ($0.26) | ($0.49) | ($0.79) | ($0.96) | ($0.63) | ($0.22) | ($0.36) |
| Shares outstanding (diluted) | 17.2 | 15.0 | 13.0 | 12.6 | 12.1 | 11.9 | 11.7 | 11.2 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|